When and how do patients with cardiac amyloidosis die?

BACKGROUND: Cardiac amyloidosis (CA) is an underappreciated cause of morbidity and mortality. Light-chain (AL) and transthyretin (ATTR) amyloidosis have different disease trajectories. No data are available on subtype-specific modes of death (MOD) in patients with CA. METHODS AND RESULTS: We retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Escher, F., Senoner, M., Doerler, J., Zaruba, M. M., Messner, M., Mussner-Seeber, C., Ebert, M., Ensinger, C., Mair, A., Kroiss, A., Ulmer, H., Schneiderbauer-Porod, S., Ebner, C., Poelzl, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952329/
https://www.ncbi.nlm.nih.gov/pubmed/31134330
http://dx.doi.org/10.1007/s00392-019-01490-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952329/
https://www.ncbi.nlm.nih.gov/pubmed/31134330
http://dx.doi.org/10.1007/s00392-019-01490-2

Ejemplares similares